Sclerosing Cholangitis
📧 Sign up to get email alerts when something new happens for Sclerosing Cholangitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-12Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis [Phase 2]
A Phase 2 clinical trial evaluating Aramchol Meglumine for Primary Sclerosing Cholangitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects With Primary Sclerosing Cholangitis. [Phase 2, Phase 3]
The randomized, double-blind, placebo-controlled Aldafermin trial for Primary Sclerosing Cholangitis (NCT06654726) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-25Clinical Trial Update: A Study Of Ursolic Acid For Primary Sclerosing Cholangitis [Phase 1]
A Phase 1 clinical trial evaluating ursolic acid for primary sclerosing cholangitis has been withdrawn (NCT03216876).
-
CLINICAL_TRIALS withdrawal · 2017-03-08Clinical Trial Update: Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease [Phase 3]
Takeda's Phase 3 trial evaluating intravenous vedolizumab for primary sclerosing cholangitis in patients with inflammatory bowel disease has…
-
CLINICAL_TRIALS withdrawal · 2015-04-28Clinical Trial Update: The Value of CT Cholangiography in Primary Sclerosing Cholangitis [Phase 2]
A Phase 2 clinical trial evaluating CT cholangiography for primary sclerosing cholangitis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.